Oppenheimer & CO Inc Moderna, Inc. Transaction History

Oppenheimer & CO Inc

  • $5.91 Billion
  • Q1 2024

A detailed history of Oppenheimer & CO Inc transactions in Moderna, Inc. stock. As of the latest transaction made, Oppenheimer & CO Inc holds 40,305 shares of MRNA stock, worth $4.79 Million. This represents 0.07% of its overall portfolio holdings.

Number of Shares
40,305
Previous 32,091 25.6%
Holding current value
$4.79 Million
Previous $3.19 Million 34.57%
% of portfolio
0.07%
Previous 0.06%

Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 06, 2024
BUY
$85.37 - $115.44 $701,229 - $948,224
8,214 Added 25.6%
40,305 $4.29 Million
Q4 2023

Feb 13, 2024
SELL
$69.51 - $104.43 $876,590 - $1.32 Million
-12,611 Reduced 28.21%
32,091 $3.19 Million
Q3 2023

Nov 07, 2023
BUY
$96.41 - $126.61 $74,139 - $97,363
769 Added 1.75%
44,702 $4.62 Million
Q2 2023

Aug 02, 2023
SELL
$118.5 - $160.53 $327,771 - $444,025
-2,766 Reduced 5.92%
43,933 $5.34 Million
Q1 2023

May 10, 2023
BUY
$135.66 - $197.02 $217,869 - $316,414
1,606 Added 3.56%
46,699 $7.17 Million
Q4 2022

Feb 07, 2023
SELL
$118.38 - $210.04 $472,217 - $837,849
-3,989 Reduced 8.13%
45,093 $8.1 Million
Q3 2022

Nov 14, 2022
SELL
$118.07 - $194.18 $432,490 - $711,281
-3,663 Reduced 6.94%
49,082 $5.8 Million
Q2 2022

Aug 08, 2022
SELL
$117.13 - $176.59 $1.68 Million - $2.54 Million
-14,369 Reduced 21.41%
52,745 $7.53 Million
Q1 2022

May 12, 2022
BUY
$126.46 - $235.05 $925,181 - $1.72 Million
7,316 Added 12.23%
67,114 $11.6 Million
Q4 2021

Feb 02, 2022
SELL
$225.82 - $368.51 $2.03 Million - $3.3 Million
-8,968 Reduced 13.04%
59,798 $15.2 Million
Q3 2021

Nov 12, 2021
SELL
$221.9 - $484.47 $4.78 Million - $10.4 Million
-21,558 Reduced 23.87%
68,766 $26.5 Million
Q2 2021

Aug 03, 2021
SELL
$129.91 - $234.98 $1.1 Million - $1.99 Million
-8,470 Reduced 8.57%
90,324 $21.2 Million
Q1 2021

May 10, 2021
BUY
$109.18 - $185.98 $2.79 Million - $4.75 Million
25,539 Added 34.86%
98,794 $12.9 Million
Q4 2020

Feb 11, 2021
SELL
$65.74 - $169.86 $6,113 - $15,796
-93 Reduced 0.13%
73,255 $7.65 Million
Q3 2020

Nov 13, 2020
BUY
$54.34 - $94.85 $233,553 - $407,665
4,298 Added 6.22%
73,348 $5.19 Million
Q2 2020

Aug 11, 2020
BUY
$29.67 - $80.0 $876,985 - $2.36 Million
29,558 Added 74.85%
69,050 $4.43 Million
Q1 2020

May 08, 2020
BUY
$17.78 - $31.58 $702,167 - $1.25 Million
39,492 New
39,492 $1.18 Million

Others Institutions Holding MRNA

# of Institutions
1,036
Shares Held
245M
Call Options Held
12.1M
Put Options Held
9.36M
View Full List

About Moderna, Inc.

MRNA Quotes by TradingView
  • Ticker MRNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 391,200,000
  • Market Cap $46.5B
  • Description
  • Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...
More about MRNA
Track This Portfolio

Track Oppenheimer & CO Inc Portfolio

Follow Oppenheimer & CO Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Oppenheimer & CO Inc, based on Form 13F filings with the SEC.

News

Stay updated on Oppenheimer & CO Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email